Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): An open-label, randomised, phase 3 trial

1. Middleton, G.
2. Silcocks, P.
3. Cox, T.
4. Valle, J.
5. Wadsley, J.
6. Propper, D.
7. Coxon, F.
8. Ross, P.
9. Madhusudan, S.
10. Roques, T.
11. Cunningham, D.
12. Falk, S.
13. Wadd, N.
14. Harrison, M.
15. Corrie, P.
16. Iveson, T.
17. Robinson, A.
18. McAdam, K.
19. Eatock, M.
20. Evans, J.
21. Archer, C.
22. Hickish, T.
23. Garcia-Alonso, A.
24. Nicolson, M.
25. Steward, W.
26. Anthoney, A.
27. Greenhalf, W.
28. Shaw, V.
29. Costello, E.
30. Naisbitt, D.
31. Rawcliffe, C.
32. Nanson, G.
33. Neoptolemos, J.
34. Show all authors +